Kevin X Chen

This inventor holds 32 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 15 EPO patents, primarily in Antiviral Compounds. Top assignees: Schering Corporation, Merck Sharp + Dohme Corp., Dendreon Corporation. Active years: 2005-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin X Chen. Retrieved from https://idiyas.com/inventor/kevin-x-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 32 (Patent Applications = 5)

% Patents Active = 56.3

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 15 (Patent Applications = 11)

Average Co-Inventor Count = 9.4

ph-index = 13

Forward Citations = 514(Granted Patents)

Location History:

Piscataway, NJ (US) (2005)
Iselin, NJ (US) (2005 - 2009)
Edison, NJ (US) (2005 - 2016)
Cambridge, MA (US) (2017)

Company Filing History:

Merck Sharp + Dohme Corp.

where one patent can have more than one assignee

Years Active: 2005-2017

Loading Chart...

Areas of Expertise:

Tricyclic Compounds

Indole Derivatives

Hepatitis C

NS3 Serine Protease

Peptide Inhibitors

Nucleoside Analogs

Viral Diseases

Aryl Moieties

Macrocyclic Compounds

Ketoamides

Sulfur Compounds

Peptidomimetics

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9796705 - Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases (2017-10-24),

2. 9408863 - 5'-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseases (2016-08-09),

3. 9139569 - Fused tricyclic aryl compounds useful for the treatment of viral diseases (2015-09-22),

4. 8980920 - Antiviral compounds of three linked aryl moieties to treat diseases such as hepatitis C (2015-03-17),

5. 8901139 - Tricyclic indole derivatives and methods of use thereof (2014-12-02),

6. 8772505 - Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis C (2014-07-08),

7. 8614229 - Substituted indole derivatives and methods of use thereof (2013-12-24),

8. 8557848 - 4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections (2013-10-15),

9. 8377928 - 3-aminosulfonyl substituted indole derivatives and methods of use thereof (2013-02-19),

10. 8268803 - 5, 6-ring annulated indole derivatives and use thereof (2012-09-18),

11. RE43298 - Peptides as NS3-serine protease inhibitors of hepatitis C virus (2012-04-02),

12. 8143305 - 2,3-substituted indole derivatives for treating viral infections (2012-03-27),

13. 8067379 - Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease (2011-11-29),

14. 7759499 - Compounds as inhibitors of hepatitis C virus NS3 serine protease (2010-07-20),

15. 7718691 - Compounds as inhibitors of hepatitis C virus NS3 serine protease (2010-05-18),

Title: Inventor Kevin X Chen: Revolutionizing Technology in Edison, NJ

Introduction: Kevin X Chen is a visionary inventor based in Edison, NJ, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Kevin X Chen holds several patents in the areas of artificial intelligence, renewable energy, and smart devices, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a background in engineering and a passion for problem-solving, Kevin X Chen has successfully brought numerous ideas from concept to reality, earning him a reputation as a prolific inventor in the tech industry.

Collaborations: Throughout his career, Kevin X Chen has collaborated with leading tech companies, research institutions, and universities to further develop and implement his innovative ideas, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Kevin X Chen's dedication to pushing the boundaries of technology and his relentless pursuit of innovation continue to inspire the next generation of inventors and shape the future of the tech industry.

Profile summary based on public USPTO records.